GABRIELLA KEEFE: Open Payments
NPI 1821673492 · GRAND HAVEN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 11 payments from 8 companies in 2025. Trend: 2023 $448 · 2024 $374 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $365 |
| Janssen Scientific Affairs, LLC | 1 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $117 |
| PFIZER INC. | 1 | $68 |
| Gilead Sciences, Inc. | 1 | $60 |
| Neurocrine BioSciences, Inc. | 1 | $49 |
| Dexcom, Inc. | 1 | $35 |
| Biogen, Inc. | 1 | $26 |
Products named: SIGNIA, TREMFYA, JARDIANCE, INTERSTIM, VENASEAL, VYNDAQEL, Livdelzi, INGREZZA.
Industry payments across MI — which companies pay providers there.
